Close Menu

China's Biotech Plan

China's biotechnology industry is likely to reach a total output value of 4 trillion yuan — $630 billion — by the end of 2015, reports China Daily's Gao Yuan. The pharmaceutical sector is expected to contribute about 90 percent of that value, Yuan says, adding that, according to China Securities Journal, the country's government is considering a five-year development plan for the industry.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.